Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.107 (
DAT
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Presynaptic reuptake, mediated by the dopamine (DA) transporter (
DAT
), terminates DAergic neurotransmission and constrains extracellular DA levels. Addictive and therapeutic psychostimulants inhibit DA reuptake and multiple
DAT
coding variants have been reported in patients with neuropsychiatric disorders. These findings underscore that
DAT
is critical for DA neurotransmission and homeostasis.
DAT
surface availability is regulated acutely by endocytic trafficking, and considerable effort has been directed toward understanding mechanisms that govern
DAT
's plasma membrane expression and postendocytic fate. Multiple studies have demonstrated
DAT
endocytic recycling and enhanced surface delivery in response to various stimuli. Paradoxically, imaging studies have not detected
DAT
targeting to classic recycling endosomes, suggesting that internalized
DAT
targets to either degradation or an undefined recycling compartment. Here, we leveraged PRIME (
PR
obe
I
ncorporation
M
ediated by
E
nzyme) labeling to couple surface
DAT
directly to fluorophore, and tracked
DAT
's postendocytic itinerary in immortalized mesencephalic cells. Following internalization,
DAT
robustly targeted to retromer-positive endosomes, and
DAT
/retromer colocalization was observed in male mouse dopaminergic somatodendritic and terminal regions. Short hairpin RNA-mediated Vps35 knockdown revealed that
DAT
endocytic recycling requires intact retromer.
DAT
also targeted
rab7
-positive endosomes with slow, linear kinetics that were unaffected by either accelerating
DAT
internalization or binding a high-affinity cocaine analog. However, cocaine increased
DAT
exit from retromer-positive endosomes significantly. Finally, we found that the
DAT
carboxy-terminal PDZ-binding motif was required for
DAT
recycling and exit from retromer. These results define the
DAT
recycling mechanism and provide a unifying explanation for previous, seemingly disparate,
DAT
endocytic trafficking findings.
SIGNIFICANCE STATEMENT
The neuronal dopamine (DA) transporter (
DAT
) recaptures released DA and modulates DAergic neurotransmission, and a number of
DAT
coding variants have been reported in several DA-related disorders, including infantile parkinsonism, attention-deficit/hyperactivity disorder and autism spectrum disorder.
DAT
is also competitively inhibited by psychostimulants with high abuse potential. Therefore, mechanisms that acutely affect
DAT
availability will likely exert significant impact on both normal and pathological DAergic homeostasis. Here, we explore the cellular mechanisms that acutely control
DAT
surface expression. Our results reveal the intracellular mechanisms that mediate
DAT
endocytic recycling following constitutive and regulated internalization. In addition to shedding light on this critical process, these findings resolve conflict among multiple, seemingly disparate, previous reports on
DAT
's postendocytic fate.
...
PMID:The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach. 2884 7